Bcl-2 antagonists and cancer: from the clinic, back to the bench

被引：7
|
作者：
M Degli Esposti
机构：
[1] Faculty of Life Sciences,
[2] University of Manchester,undefined
来源：
Cell Death & Disease | 2010年 / 1卷 / 4期
关键词：
D O I：
10.1038/cddis.2010.15
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：e37 / e37
相关论文
共 50 条
  • [1] BCL-2 family antagonists for cancer therapy
    Guillaume Lessene
    Peter E. Czabotar
    Peter M. Colman
    Nature Reviews Drug Discovery, 2008, 7 : 989 - 1000
  • [2] BCL-2 family antagonists for cancer therapy
    Lessene, Guillaume
    Czabotar, Peter E.
    Colman, Peter M.
    NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (12) : 989 - 1000
  • [3] BCL-2 in lymphomas: From laboratory to clinic
    Cunningham, D
    Webb, A
    Cotter, F
    CANCER GENE THERAPY, 1997, 4 (01) : 66 - 66
  • [4] BCL-2 family antagonists
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (12) : 969 - 969
  • [5] Opiate and cocaine addiction: from bench to clinic and back to the bench
    Kreek, Mary Jeanne
    Zhou, Yan
    Butelman, Eduardo R.
    Levran, Orna
    CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (01) : 74 - 80
  • [6] A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy
    W J Placzek
    J Wei
    S Kitada
    D Zhai
    J C Reed
    M Pellecchia
    Cell Death & Disease, 2010, 1 : e40 - e40
  • [7] A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy
    Placzek, W. J.
    Wei, J.
    Kitada, S.
    Zhai, D.
    Reed, J. C.
    Pellecchia, M.
    CELL DEATH & DISEASE, 2010, 1 : e40 - e40
  • [8] Regulatory T cells: from the bench to the clinic and back
    Al Dulaijan, Basmah S.
    Mansouri, Amr
    Karnyski, Jordan
    Azzi, Jamil
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2018, 23 (01) : 1 - 7
  • [9] Human genetics moves from clinic to bench - and back
    Miroslava Ogorelkova
    Xavier Estivill
    Genome Biology, 6 (9)
  • [10] Bcl-2 antagonists: a proof of concept for CLL therapy
    Kumudha Balakrishnan
    Varsha Gandhi
    Investigational New Drugs, 2013, 31 : 1384 - 1394
12345